Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chelation Therapy of Iron Overload With Oral Pyridoxal Isonicotinoyl Hydrazone

NCT00000588 is registered in ClinicalTrials.gov with Case Western Reserve University as lead sponsor.

NCT NCT00000588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00000588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chelation Therapy of Iron Overload With Oral Pyridoxal Isonicotinoyl Hydrazone
Lead sponsor
Case Western Reserve University
Phase
Phase 2
Overall status
Completed
Start date
June 5, 1989
Completion date
March 31, 1995
Enrollment
120 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia (iron-loading), beta-thalassemia, hematologic diseases, hemoglobinopathies, iron overload, thalassemia